|
|
|
41
|
A681HB
|
ZOVILAM 150MG|300MG TAB (MAT) LAMIVUDINE|ZIDOVUDINE (BL)
|
LAMIVUDINE|ZIDOVUDINE
|
ZOVILAM
|
60'S
|
BL
|
30.17
|
0.5029
|
TAB
|
60
|
BOX
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180820
|
NRTI
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
NRTI
|
|
|
|
|
40
|
A681HC
|
EFAVIRENZ | EMTRICITABINE | TENOFOVIR 600MG | 200MG | 300MG TAB (MCP/AHI)
|
EFAVIRENZ|EMTRICITABINE|TENOFOVIR
|
EFAVIRENZ|EMTRICITABINE|TENOFOVIR
|
30'S
|
BL
|
21.80
|
0.73
|
TABLET
|
0
|
TAB
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180892
|
ANTIRETROVIRALS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
A681HC
|
EFAVIRENZ|EMTRICITABINE|TENOFOVIR 600MG|200MG|300MG TAB (MCP (BL)
|
EFAVIRENZ|EMTRICITABINE|TENOFOVIR
|
EFAVIRENZ|EMTRICITABINE|TENOFOVIR
|
30'S
|
BL
|
19.19
|
0.6397
|
TAB
|
60
|
BOX
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180816
|
NNRTI
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
NNRTI
|
|
|
|
|
40
|
A681HE
|
ABACAVIR | LAMIVUDINE 600MG | 300MG TAB (MAT/AHI)
|
ABACAVIR|LAMIVUDINE
|
ABACAVIR|LAMIVUDINE
|
30'S
|
BL
|
63.61
|
2.12
|
TABLET
|
0
|
TAB
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180892
|
ANTIRETROVIRALS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
A681HG
|
DUOVIR 150MG | 300MG TAB (CIP/AHI) LAMIVUDINE | ZIDOVUDINE
|
LAMIVUDINE|ZIDOVUDINE
|
DUOVIR
|
60'S
|
BL
|
53.47
|
0.89
|
TABLET
|
0
|
TAB
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180892
|
ANTIRETROVIRALS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
A681HJ
|
EMTRICITABINE | TENOFOVIR 200MG | 300MG TAB (MCP/AHI)
|
EMTRICITABINE|TENOFOVIR
|
EMTRICITABINE|TENOFOVIR
|
30'S
|
BL
|
15.98
|
0.53
|
TABLET
|
0
|
TAB
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180892
|
ANTIRETROVIRALS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
A681HJ
|
EMTRICITABINE|TENOFOVIR 200MG|300MG TAB (MCP) (BL)
|
EMTRICITABINE|TENOFOVIR
|
EMTRICITABINE|TENOFOVIR
|
30'S
|
BL
|
13.24
|
0.4413
|
TAB
|
60
|
BOX
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180820
|
NRTI
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
NRTI
|
|
|
|
|
40
|
A681HK
|
LOPINAVIR | RITONAVIR 200MG | 50MG TAB (MAT/AHI)
|
LOPINAVIR|RITONAVIR
|
LOPINAVIR|RITONAVIR
|
120'S
|
BL
|
85.63
|
0.71
|
TABLET
|
0
|
TAB
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180892
|
ANTIRETROVIRALS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
A681HL
|
EMTRICITABINE | TENOFOVIR 200MG | 300MG TAB (MAT/AHI)
|
EMTRICITABINE|TENOFOVIR
|
EMTRICITABINE|TENOFOVIR
|
30'S
|
BL
|
29.19
|
0.97
|
TABLET
|
0
|
TAB
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180892
|
ANTIRETROVIRALS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
A681HL
|
EMTRICITABINE|TENOFOVIR 200MG|300MG TAB (MAT) (BL)
|
EMTRICITABINE|TENOFOVIR
|
EMTRICITABINE|TENOFOVIR
|
30'S
|
BL
|
27.67
|
0.9224
|
TAB
|
60
|
BOX
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180820
|
NRTI
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
NRTI
|
|
|
|
|
41
|
A681HN
|
APO-EMTRICITABINE|TENOFOVIR 200MG TAB (APO) (BL)
|
EMTRICITABINE|TENOFOVIR
|
APO-EMTRICITABINE|TENOFOVIR
|
30'S
|
BL
|
34.93
|
1.1644
|
TAB
|
60
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081892
|
ANTIVIRALS, MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTIVIRALS, MISCELLANEOUS
|
|
|
|
|
41
|
A681HQ
|
EFAVIRENZ|EMTRICITABINE|TENOFOVIR 600MG|200MG|300MG TAB (HET (BL)
|
EFAVIRENZ|EMTRICITABINE|TENOFOVIR
|
EFAVIRENZ|EMTRICITABINE|TENOFOVIR
|
30'S
|
BL
|
46.76
|
1.5585
|
TAB
|
60
|
BOTT
|
HET
|
HETERO DRUGS LTD
|
ALI
|
ALL HEALTH INC
|
|
081892
|
ANTIVIRALS, MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTIVIRALS, MISCELLANEOUS
|
|
|
|
|
41
|
A681HR
|
TRINISTEM 600MG|200MG|300MG TAB (REM) EFAVIRENZ|EMTRICITABIN (BL)
|
EFAVIRENZ|EMTRICITABINE
|
TRINISTEM
|
30'S
|
BL
|
60.32
|
2.0107
|
TAB
|
60
|
CAN
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
081892
|
ANTIVIRALS, MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTIVIRALS, MISCELLANEOUS
|
|
|
|
|
41
|
A681HS
|
DUOVIR 150MG|300MG TAB (CIP) LAMIVUDINE|ZIDOVUDINE (BL)
|
LAMIVUDINE|ZIDOVUDINE
|
DUOVIR
|
700'S
|
BL
|
119.14
|
0.1702
|
TAB
|
60
|
BOTT
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081892
|
ANTIVIRALS, MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTIVIRALS, MISCELLANEOUS
|
|
|
|
|
41
|
A681HT
|
LAMIVUDINE|ZIDOVUDINE 150MG TAB (MCP) (BL)
|
LAMIVUDINE|ZIDOVUDINE
|
LAMIVUDINE|ZIDOVUDINE
|
60'S
|
BL
|
19.98
|
0.333
|
TAB
|
60
|
BOX
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081892
|
ANTIVIRALS, MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTIVIRALS, MISCELLANEOUS
|
|
|
|
|
41
|
A681HV
|
EMTRICITABINE|TENOFOVIR 200MG|300MG CAP (HET) (BL)
|
EMTRICITABINE|TENOFOVIR
|
EMTRICITABINE|TENOFOVIR
|
60'S
|
BL
|
46.76
|
0.7793
|
CAP
|
60
|
BOTT
|
HET
|
HETERO DRUGS LTD
|
ALI
|
ALL HEALTH INC
|
|
081892
|
ANTIVIRALS, MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTIVIRALS, MISCELLANEOUS
|
|
|
|
|
41
|
A681HX
|
TRIUMEQ 600MG|50MG|300MG TAB (GSK) ABACAVIR|DOLUTEGRAVIR|LAM (BQ)
|
ABACAVIR|DOLUTEGRAVIR|LAMIVUDINE
|
TRIUMEQ
|
30'S
|
BQ
|
815.5
|
27.1833
|
TAB
|
0
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
08180812
|
INTEGRASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
INTEGRASE INHIBITORS
|
|
|
|
|
40
|
A6911
|
TRILEPTAL 300MG TAB (NVS/COL) OXCARBAZEPINE
|
OXCARBAZEPINE
|
TRILEPTAL
|
20'S
|
C
|
27.18
|
1.36
|
TABLET
|
0
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A6911
|
TRILEPTAL 300MG TAB (NVS) OXCARBAZEPINE (C)
|
OXCARBAZEPINE
|
TRILEPTAL
|
20'S
|
C
|
27.18
|
1.3592
|
TAB
|
120
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
A691J
|
APO-OXCARBAZEPINE 300MG TAB (APO/COL)
|
OXCARBAZEPINE
|
APO-OXCARBAZEPINE
|
100'S
|
A
|
59.42
|
0.59
|
TABLET
|
120
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|